Boardroom Alpha
Boardroom Alpha
KMB · Current Report (Form 8-K) · Filed May 14, 2026

Kimberly Clark Corp — Current Report (Form 8-K)

Form
8-K
Filed
May 14, 2026
Period
May 14, 2026
Ticker
KMB
Accession
0001628280-26-035124
Boardroom Alpha · Filing insights

Stockholders re-elected all director nominees and ratified Deloitte as independent auditor for 2026. They also approved executive compensation on an advisory basis and rejected the independent Board Chair proposal.

About Kimberly Clark Corp
Market cap
$32.4B
1Y TSR
−23.8%
3Y TSR
−7.1%
Board grade
C-
Sector
Consumer Defensive
CEO
Michael D Hsu
Last annual meeting: May 14, 2026 · View full Kimberly Clark Corp profile →
pre-20260514

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: May 14, 2026
(Date of earliest event reported)

K-C Logo Blue (JPG).jpg
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)
Delaware1-22539-0394230
(State or other jurisdiction of incorporation)(Commission file number)(I.R.S. Employer Identification No.)
P.O. Box 619100
Dallas, TX
75261-9100
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code: (972) 281-1200

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock-$1.25 par valueKMBThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.07    Submission of Matters to a Vote of Security Holders.

(a)    The Corporation held its 2026 Annual Meeting of Stockholders on May 14, 2026.

(b)    The stockholders (1) elected all of the Corporation’s nominees for director, (2) ratified the selection of Deloitte & Touche LLP as our independent auditors for 2026, (3) approved the compensation of our named executive officers on an advisory basis, and (4) did not approve the stockholder proposal to require an independent Board Chair.

The final voting results on each of the matters submitted to a vote are as follows:
1.Election of Directors:

Name
Votes ForVotes Against
Abstentions
Broker Non-Votes
Sylvia M. Burwell240,191,8802,496,791545,73846,305,035
John W. Culver239,464,0683,206,688563,87546,305,035
Michael D. Hsu229,430,25911,170,6422,633,72946,305,035
Mae C. Jemison, M.D.236,407,4196,286,180541,03246,305,035
Deeptha Khanna240,250,2942,417,785566,55146,305,035
S. Todd Maclin240,068,3112,593,494572,82546,305,035
Deirdre A. Mahlan240,307,0092,371,191556,43046,305,035
Sherilyn S. McCoy240,670,3462,018,752545,53246,305,035
Christa S. Quarles239,601,4723,080,850552,11646,305,035
Jaime A. Ramirez
239,960,9512,693,381580,29946,305,035
Joseph Romanelli240,360,0822,297,925576,62446,305,035
Dunia A. Shive237,146,7445,488,424599,46346,305,035
Mark T. Smucker238,171,2394,488,749574,64346,305,035
2.Ratification of Deloitte & Touche LLP as Independent Auditors for 2026:
Votes ForVotes Against
Abstentions
271,479,16817,253,057807,439

3.Advisory Approval of Named Executive Officer Compensation:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
227,376,23114,569,7071,288,69246,305,035

4.Stockholder Proposal to Require Independent Board Chair:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
81,710,364159,903,1971,621,02546,305,035




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.







KIMBERLY-CLARK CORPORATION
Date: May 14, 2026By:

/s/ Grant B. McGee
Grant B. McGee
Senior Vice President and General Counsel




From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Kimberly Clark Corp (KMB)

Reference

Frequently asked questions

When did Kimberly Clark Corp file this 8-K?
Kimberly Clark Corp (KMB) filed this Current Report (Form 8-K) with the SEC on May 14, 2026. The accession number assigned by EDGAR is 0001628280-26-035124.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders re-elected all director nominees and ratified Deloitte as independent auditor for 2026. They also approved executive compensation on an advisory basis and rejected the independent Board Chair proposal. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Kimberly Clark Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Kimberly Clark Corp has filed under CIK 55785, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer